Why the study?
Early assessment of target hit in anti-cancer therapies is a major task in oncologic imaging.
Does multiparametric MRI detect early target hit of tTF-NGR in patients with advanced solid malignancies?
Does multiparametric MRI detect early target hit of tTF-NGR in patients with advanced solid malignancies?
Multiparametric MRI can evaluate changes in tumor perfusion as early as five hours after initiation of a tumor vessel occluding therapy.
Answers are grounded in this paper and cite their sources.
Multiparametric MRI enables early target hit assessment in phase I tTF-NGR trials; leaves open its role in guiding therapy pending larger studies.
Early assessment of target hit in anti-cancer therapies is a major task in oncologic imaging. In this study, immediate target hit and effectiveness of CD13-targeted tissue factor tTF-NGR in patients with advanced malignant disease enrolled in a phase I trial was assessed using a multiparametric MRI protocol. Seventeen patients with advanced solid malignancies were enrolled in the trial and received tTF-NGR for at least one cycle of five daily infusions. Tumor target lesions were imaged with multiparametric MRI before therapy initiation, five hours after the first infusion and after five days. The imaging protocol comprised ADC, calculated from DWI, and DCE imaging and vascular volume fraction (VVF) assessment. DCE and VVF values decreased within 5 h after therapy initiation, indicating early target hit with a subsequent decrease in tumor perfusion due to selective tumor vessel occlusion and thrombosis induced by tTF-NGR. Simultaneously, ADC values increased at five hours after tTF-NGR administration. In four patients, treatment had to be stopped due to an increase in troponin T hs, with subsequent anticoagulation. In these patients, a reversed effect, with DCE and VVF values increasing and ADC values decreasing, was observed after anticoagulation. Changes in imaging parameters were independent of the mean vessel density determined by immunohistochemistry. By using a multiparametric imaging approach, changes in tumor perfusion after initiation of a tumor vessel occluding therapy can be evaluated as early as five hours after therapy initiation, enabling early assessment of target hit.
No takes yet. Share an insight, caveat, or question.
Gerwing et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: